BioNTech’s BNT116 mRNA cancer vaccine trial currently open at MD Anderson and Johns Hopkins
Exciting news for the RET community! BioNTech’s BNT116 mRNA cancer vaccine trial now enables combination…
Irene Guijarro MunozApril 27, 2026










